STMN1 is expressed in various carcinomatosis such as ovarian cancer 89, endometrial cancer 90, cervical cancer 91, hepatocellular carcinoma 92, and bladder cancer 93, and inhibition of STMN1 can reduce cell viability and migration potential. This evidence concerns the gene STMN1 and ovarian cancer.